Standard breast tumor classification has long relied on morphological and anatomical criteria such as tumor size and extension (TNM staging), histopathological features (tumor grade) and expression of protein markers such as the estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2) oncogene [1,2]. This evidence concerns the gene ERBB2 and breast neoplasm.